- Home
- DCTH vs TSI Comparison
DCTH vs TSI Comparison
Compare DCTH & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCTH | TSI |
|---|---|---|
| Founded | 1988 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.2M | 234.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DCTH | TSI |
|---|---|---|
| Price | $9.69 | $4.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $22.60 | N/A |
| AVG Volume (30 Days) | ★ 997.4K | 106.8K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.46% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $79,603,000.00 | N/A |
| Revenue This Year | $135.11 | N/A |
| Revenue Next Year | $36.30 | N/A |
| P/E Ratio | $281.11 | ★ N/A |
| Revenue Growth | ★ 251.54 | N/A |
| 52 Week Low | $8.12 | $4.48 |
| 52 Week High | $18.23 | $4.87 |
Technical Indicators
Market Signals| Indicator | DCTH | TSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | 54.20 |
| Support Level | $8.12 | $4.90 |
| Resistance Level | $9.39 | $4.91 |
| Average True Range (ATR) | 0.46 | 0.04 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 84.15 | 70.00 |
Price Performance
Historical ComparisonAbout DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.